|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/4468 | |
| A61P 25/00 |
| (11) | Number of the document | 2200610 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08831500.7 |
| Date of filing the European patent application | 2008-09-19 | |
| (97) | Date of publication of the European application | 2010-06-30 |
| (45) | Date of publication and mention of the grant of the patent | 2018-01-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/077139 |
| Date | 2008-09-19 |
| (87) | Number | WO 2009/039460 |
| Date | 2009-03-26 |
| (30) | Number | Date | Country code |
| 974426 P | 2007-09-21 | US | |
| 986250 P | 2007-11-07 | US | |
| 50976 | 2008-05-06 | US |
| (72) |
HACKSELL, Uli, US
MCFARLAND, Krista, US
|
| (73) |
Acadia Pharmaceuticals Inc.,
3611 Valley Centre Drive, Suite 300, San Diego, CA 92130,
US
|
| (54) | CO-ADMINISTRATION OF PIMAVANSERIN WITH OTHER AGENTS |
| CO-ADMINISTRATION OF PIMAVANSERIN WITH OTHER AGENTS |